[1] |
Drachman D.Myasthenia Gravis[J].Semin Neurol,2016,36(5):419-424.
|
[2] |
Marx A,Willcox N,Leite M,et al.Thymoma and paraneoplastic myasthenia gravis[J].Autoimmunity,2010,43(5-6):413-427.
|
[3] |
Blalock A,Mason MF,Morgan HJ,et al.Myasthenia gravis and tumors of the thymic region:report of a case in which the tumor was removed[J].Ann Surg,1939,110(4):544-561.
|
[5] |
Evoli A,Meacci E.An update on thymectomy in myasthenia gravis[J].Expert Rev Neurother,2019,19(9):823-833.
|
[7] |
中国免疫学会神经免疫学分会,中华医学会神经病学分会神经免疫学组.重症肌无力诊断和治疗中国专家共识[J].中国神经免疫学和神经病学杂志,2012,19(6):401-408.
|
[8] |
李荣耀.一种围手术期管理体系在重症肌无力患者中的应用价值研究[D].郑州:郑州大学,2019.
|
[4] |
Bachmann K,Burkhardt D,Schreiter I,et al.Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement[J].Surgery,2009,145(4):392-398.
|
[6] |
Watanabe A,Watanabe T,Obama T,et al.Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis[J].J Thorac Cardiovasc Surg,2004,127(3):868-876.
|
[9] |
Wolfe GI,Kaminski HJ,Aban IB,et al.Randomized Trial of Thymectomy in Myasthenia Gravis[J].N Engl J Med,2016,375(6):511-522.
|
[10] |
Leuzzi G,Meacci E,Cusumano G,et al.Thymectomy in myasthenia gravis:proposal for a predictive score of postoperative myasthenic crisis[J].Eur J Cardiothorac Surg,2014,45(4):e76- 88;discussion e88.
|
[11] |
Kato T,Kawaguchi K,Fukui T,et al.Risk Factors for the Exacerbation of Myasthenic Symptoms After Surgical Therapy for Myasthenia Gravis and Thymoma[J].Semin Thorac Cardiovasc Surg,2020,32(2):378-385.
|
[12] |
Li Y,Wang H,Chen P,et al.Clinical outcome and predictive factors of postoperative myasthenic crisis in 173 thymomatous myasthenia gravis patients[J].Int J Neurosci,2018,128(2):103-109.
|
[13] |
Mouri H,Jo T,Matsui H,et al.Effect of Sugammadex on Postoperative Myasthenic Crisis in Myasthenia Gravis Patients:Propensity Score Analysis of a Japanese Nationwide Database[J].Anesth Analg,2020,130(2):367-373.
|
[14] |
Ponseti JM,Gamez J,Vilallonga R,et al.Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis[J].Eur J Cardiothorac Surg,2008,34(5):1062-1067.
|
[15] |
Gung Y,Zhang H,Li S,et al.Sternotomy versus video-assisted thoracoscopic surgery for thymectomy of myasthenia gravis patients:A meta-analysis[J].Asian J Endosc Surg,2016,9(4):285-294.
|
[16] |
Meyer DM,Herbert MA,Sobhani NC,et al.Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches[J].Ann Thorac Surg,2009,87(2):385- 390;discussion 390-391.
|
[17] |
Lin Q,Zhang Y,Yang L.Single-center retrospective analysis of 162 cases with thymoma complicating myasthenia gravis[J].J BUON,2017,22(3):741-745.
|
[18] |
Chu XY,Xue ZQ,Wang RW,et al.Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy[J].Chin Med J,2011,124(8):1246-1250.
|
[19] |
Xue L,Wang L,Dong J,et al.Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis[J].Eur J Cardiothorac Surg,2017,52(4):692-697.
|
[20] |
李翠翠,孙振锋,朱应超,等.重症肌无力合并胸腺瘤手术治疗的近期疗效及危象的相关因素探讨[J].临床和实验医学杂志,2019,18(9):989-992.
|
[21] |
李金燕.胸腺瘤WHO病理分型和Maosaoka分期与重症肌无力的关系[D].大连:大连医科大学,2016.
|